Reactive oxygen species and rosacea

Cutis

Volumn 74, Issue 3 SUPPL., 2004, Pages 17-20

  Jones, David ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; MALONALDEHYDE; METRONIDAZOLE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TETRACYCLINE DERIVATIVE;

ANTIOXIDANT ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; PATHOPHYSIOLOGY; REVIEW; ROSACEA; SKIN BIOPSY; ULTRAVIOLET RADIATION;

ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; HUMANS; METRONIDAZOLE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; ROSACEA; TETRACYCLINES;

EID: 4944223168     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Dahl MV. Pathogenesis of rosacea. Adv Dermatol. 2001;17:29-45.
2. Millikan L. The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed. 2003;2:43-47.
3. Powell FC. What's going on in rosacea? J Eur Acad Dermatol Venereol. 2000;14:351-352.
4. Miyachi Y, Yoshioka A, Imamura S, et al. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol. 1986;86:449-453.
5. Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol. 1993;28:443-448.
6. Shalita A, Leyden J. Mechanism-based selection of pharmacologic agents for rosacea. Cutis. 2004;73(suppl 1):15-18.
7. Powell FC. Rosacea and the pilosebaceous follicle. Cutis. 2004;74(suppl 13):9-12.
8. Dahl MV. Rosacea subtypes: a treatment algorithm. Cutis. 2004;74(suppl 3):21-27.
9. Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol. Feb 1986;114:231-234.
10. Miyachi Y. Potential antioxidant mechanism of action for metronidazole: implications for rosacea management. Adv Ther. 2001;18:237-243.
11. Jain A, Sangal L, Basal E, et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils [abstract]. Dermatol Online J. 2002;8:2.
12. Akamatsu H, Komura J, Asada Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res. 1991;283:162-166.
13. Kang S, Fisher GJ, Voorhees JJ. Photoaging: pathogenesis, prevention, and treatment. Clin Geriatr Med. 2001;17:643-659, v-vi.
14. Oztas MO, Balk M, Ogus E, et al. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol. 2003;28:188-192.
15. Niwa Y, Kasama T, Miyachi Y, et al. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies. Life Sci. 1989;44:1655-1664.
16. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170-177.
17. Neumann E, Frithz A. Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea. Int J Dermatol. 1998;37:263-266.
18. Pinnell SR. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol. 2003;48:1-19.
19. Akamatsu H, Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology. 1998;196:82-85.
20. Akamatsu H, Oguchi M, Nishijima S, et al. The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne. Arch Dermatol Res. 1990;282:449-454.